Exchange Announcement • 18 Dec 2024 20:30
Exchange Announcement • 13 Nov 2024 05:02
Exchange Announcement • 12 Nov 2024 08:00
Exchange Announcement • 24 Oct 2024 04:11
Exchange Announcement • 07 Aug 2024 05:31
ENTITY
Corvus Pharmaceuticals (CRVS US)
Corvus Pharmaceuticals (CRVS US)
1
Analysis
Health Care • United States
Corvus Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the development of novel and first-in-class agents that target the immune system to treat patients with cancer. Corvus Pharmaceuticals offers its services in the United States.
more
x